Qatar Pharma
About Qatar Pharma
Categories
-
QA -
2019On CPHI since
Products from Qatar Pharma (3)
-
Product 0.5%w/v Levofloxacin Injection
0.5% w/v Levofloxacin Injection is indicated in adults for the treatment of the following infections : Community-acquired pneumonia, Complicated skin and soft tissue infection. For the above-mentioned infections 0.5% w/v Levofloxacin Injection should be used only when it is considered inappropria... -
Product 0.5%w/v Metronidazole Injection USP
0.5%w/v Metronidazole Injection USP is indicated in adults and children when oral medication is not possible for the following indications: - The prophylaxis of postoperative infections due to sensitive anaerobic bacteria particularly s... -
Product 1%w/v & 2%w/v Lidocaine Hydrochloride Injection, USP
Suppression of ventricular extrasystoles and ventricular tachycardia, especially after an acute myocardial infarction. Local anaesthesia by surface infiltration, regional, epidural and caudal routes, dental anaesthesia, either alone or in combination with adrenaline. Lidocaine may also be administered by s...
Qatar Pharma Resources (1)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance